By Steven Melendez ( April 25, 2012, 7:37 PM EDT) -- New Jersey-based Watson Pharmaceuticals Inc. has agreed to buy Swiss drugmaker Actavis Group for €4.25 billion (about $5.6 billion) in a deal that would create the world's third-largest generic pharmaceuticals maker, with about $8 billion in revenue, the companies said Wednesday....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.